ATE136021T1 - Verfahren zur herstellung von n1,n4- diethylspermin - Google Patents

Verfahren zur herstellung von n1,n4- diethylspermin

Info

Publication number
ATE136021T1
ATE136021T1 AT92203575T AT92203575T ATE136021T1 AT E136021 T1 ATE136021 T1 AT E136021T1 AT 92203575 T AT92203575 T AT 92203575T AT 92203575 T AT92203575 T AT 92203575T AT E136021 T1 ATE136021 T1 AT E136021T1
Authority
AT
Austria
Prior art keywords
general formula
stands
chem
pharmaceutically acceptable
compound
Prior art date
Application number
AT92203575T
Other languages
English (en)
Inventor
Raymond J Bergeron Jr
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE136021T1 publication Critical patent/ATE136021T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/06Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
    • C07C209/08Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Pest Control & Pesticides (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
AT92203575T 1986-12-02 1987-12-01 Verfahren zur herstellung von n1,n4- diethylspermin ATE136021T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93683586A 1986-12-02 1986-12-02

Publications (1)

Publication Number Publication Date
ATE136021T1 true ATE136021T1 (de) 1996-04-15

Family

ID=25469139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92203575T ATE136021T1 (de) 1986-12-02 1987-12-01 Verfahren zur herstellung von n1,n4- diethylspermin

Country Status (6)

Country Link
EP (2) EP0536853B1 (de)
JP (1) JPH0653661B2 (de)
AT (1) ATE136021T1 (de)
CA (1) CA1305425C (de)
DE (2) DE3751764T2 (de)
ES (2) ES2059398T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5753714A (en) * 1987-02-03 1998-05-19 Merrell Pharmaceuticals Inc. Polyamine derivatives
ZA887410B (en) * 1987-10-08 1989-06-28 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents
US5654484A (en) * 1987-10-08 1997-08-05 Merrell Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
ATE120447T1 (de) * 1989-01-10 1995-04-15 Merrell Dow Pharma Polyamin-derivate als antineoplastische mittel.
US5561136A (en) * 1990-12-13 1996-10-01 Merrell Pharmaceuticals Inc. Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
GB9105489D0 (en) * 1991-03-15 1991-05-01 Johnson Matthey Plc Improvements in chemical compounds
FR2714052B1 (fr) * 1993-12-22 1996-02-02 Synthelabo Préparation de polyamines substituées sur les deux azotes terminaux.
ES2119371T3 (es) * 1993-12-27 1998-10-01 Novartis Ag Aminocompuestos insaturados para usar como un agente anticancerigeno y antiprotozoico.
US5834486A (en) * 1995-03-15 1998-11-10 Novartis Ag Piperidinyl-2-alkyl, substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation
EP0934249B1 (de) * 1996-10-18 2002-03-27 Wisconsin Alumni Research Foundation In ihrer konformation eingeschränkte polyamine und ihre verwendung als antineoplastische mittel
US5889061A (en) * 1997-10-15 1999-03-30 Wisconsin Alumni Research Foundation Conformationally restricted polyamines
US7045550B2 (en) 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
RU2017104223A (ru) * 2014-07-11 2018-08-14 Джензим Корпорейшн Полиамины с определенной главной цепью
WO2018059216A1 (zh) * 2016-09-29 2018-04-05 广州君赫生物科技有限公司 降低saicar合成酶活性的化合物及应用
CN110678452B (zh) 2017-04-20 2023-02-28 广州君赫生物科技有限公司 亚精胺及其衍生物的应用
CN110494131B (zh) * 2017-04-20 2022-11-08 广州君赫生物科技有限公司 精胺及其衍生物在制备抗肿瘤药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606348B2 (ja) * 1976-03-31 1985-02-18 三菱化学株式会社 新規ポリアミン類
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤

Also Published As

Publication number Publication date
CA1305425C (en) 1992-07-21
ES2059398T3 (es) 1994-11-16
JPS63211225A (ja) 1988-09-02
EP0270349A2 (de) 1988-06-08
DE3751764T2 (de) 1996-10-31
ES2088091T3 (es) 1996-08-01
EP0270349A3 (en) 1990-09-12
EP0536853B1 (de) 1996-03-27
EP0270349B1 (de) 1993-08-04
DE3786896T2 (de) 1993-12-23
DE3751764D1 (de) 1996-05-02
DE3786896D1 (de) 1993-09-09
EP0536853A2 (de) 1993-04-14
JPH0653661B2 (ja) 1994-07-20
EP0536853A3 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
ATE136021T1 (de) Verfahren zur herstellung von n1,n4- diethylspermin
ATE26112T1 (de) Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung.
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
ES533009A0 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
DE3762236D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
ATE57699T1 (de) Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung.
AU8004291A (en) Use of alkyl phospholipids as antiviral drugs, as well as new compounds
DE69108014D1 (de) Verfahren zur herstellung von nucleosiden und ihre analogen.
DE3768319D1 (de) Verfahren zur herstellung von o-substituierten hydroxylaminen.
ATE477227T1 (de) Verfahren zur herstellung eines trans-4-amino-1- cyclohexancarbonsäurederivats
DE3576952D1 (de) Verfahren zur herstellung von 4-phenyl-pyrrol-derivaten.
ATE277015T1 (de) Verfahren zur herstellung von 1,4-dihydropyridine sowie in diesem verfahren verwendete verbindungen
DE59306121D1 (de) Verfahren zur racemattrennung von verapamil
NO166528C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen- og indanderivater.
NO873248D0 (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
ATE176783T1 (de) Verfahren zur herstellung von urethangruppen enthaltende bisoxazolidinen
ATE101391T1 (de) Verfahren zur herstellung von in stellung 3 durch eine halogenierte gesaettigte kette substituierten cyclopropancarbonsaeurederivaten.
ATE185802T1 (de) Verfahren zur herstellung von 1-methylindazol-3- carbonsäure
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
DE69604642D1 (de) Verfahren zur herstellung von iodierten kontrastmitteln
ATE21387T1 (de) Hydrochinonabkoemmlinge, sowie verfahren zu deren herstellung.
ATE77091T1 (de) Verfahren zur herstellung von alphaaminoalkylphosphons|uren.
DE3750117D1 (de) Verfahren zur Herstellung von Indolinon-2-Derivaten.
ATE166048T1 (de) Verfahren zur herstellung von prostaglandin e
ATE127775T1 (de) Verfahren zur herstellung von alpha-omega- alkandicarbonsäuren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee